Home›Companies›Biotech & Pharma›Akadeum Life Sciences

Akadeum Life Sciences, Inc.

Cell separation kits and technology for researchers and cell therapy manufacturers.

Updated Nov 10, 2026·Latest SEC filing Jul 9, 2026·Suggest an edit

About Akadeum Life Sciences

Akadeum Life Sciences is a private company based in Ann Arbor, Michigan. It has reported $17,416,985 raised in seven offerings on Form D since June 2015. Its chief executive is Kalyan Handique.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 25, 2026Jul 9, 2026$2,130,557of $3.4M target9$236KEquityRule 506(b)Form D ↗
Apr 11, 2025Apr 25, 2025$5,633,565of $7.1M target35$160KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
May 16, 2023May 30, 2023$6,000,000of $6.5M target22$272KDebt, Securities on exerciseRule 506(b)Form D ↗
Nov 26, 2018Nov 27, 2018$900,000of $2.0M target0—Convertible debt roundRule 506(b)Form D ↗
Jul 27, 2017Jul 26, 2017amended Aug 31, 2017$1,487,800of $1.6M target19$78,305EquityRule 506(b)Form D/A ↗1 earlier filing
Not yetApr 28, 2016amended Dec 30, 2016$360,000of $1.0M target0—DebtRule 506(b)Form D/A ↗1 earlier filing
May 15, 2015Jun 3, 2015amended Aug 12, 2015$905,063of $1.0M target3$301KEquityRule 506(b)Form D/A ↗3 earlier filings
Total, seven offerings$17,416,985

The filing for the offering first filed Nov 27, 2018 reports amount sold with no investors. The filing for the offering first filed Apr 28, 2016 reports amount sold with no investors and amount sold but first sale marked as not yet made. Figures are shown as filed.

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Akadeum Life Sciences's Form D filed Jul 9, 2026.

James Militello
James Militello
Chief Financial Officer
Kalyan Handique
Kalyan Handique
Chief Executive Officer and director
JL
Jenni Li
Senior Principal at Michigan Capital Network (MCN) and director
Paul D'Amato
Paul D'Amato
CEO and Managing Director, Michigan Capital Network

Earlier filings also listed Jeffrey Williams (director, last listed Apr 2025), Dan Kidle (director, last listed Apr 2025), Brandon McNaughton (president and director, last listed Apr 2025), William Hyun (director, last listed May 2023), John Gavenonis (director, last listed May 2023), George Dunbar (director, last listed May 2023), John Younger (executive officer and director, last listed Nov 2018) and Douglas Neal (director, last listed Nov 2018).

Sources

  1. SECAKADEUM LIFE SCIENCES, INC. Form D, filed Jul 26, 2017
  2. SECAKADEUM LIFE SCIENCES, INC. Form D, filed Apr 28, 2016
  3. SECAKADEUM LIFE SCIENCES, INC. Form D/A, filed Jun 3, 2015
  4. SECAKADEUM LIFE SCIENCES, INC. Form D/A, filed Jun 3, 2015
  5. SECAKADEUM LIFE SCIENCES, INC. Form D, filed Jun 3, 2015
  6. SECAKADEUM LIFE SCIENCES, INC. filing history
  7. CompanyLeadership team
  8. CompanyBoard